OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001588972

Societal CDMO, Inc.

Societal CDMO, Inc. (CIK 0001588972, EIN 26-1523233) reported revenue of $94.64 million ($94,635,000) for FY2023 (2023-01-01 to 2023-12-31) and net income of -$13.27 million (-$13,274,000) for FY2023 (2023-01-01 to 2023-12-31), as filed in its 10-K filed 2024-03-22 (accession 0000950170-24-035480).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001588972
EIN26-1523233
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationPA
Fiscal year endDecember 31
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_0xy6d4ze3c7ss49nvcb3fr7n9y
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$94,635,000FY20232023-01-01 to 2023-12-3110-K2024-03-220000950170-24-035480RevenueFromContractWithCustomerExcludingAssessedTax
Net income-$13,274,000FY20232023-01-01 to 2023-12-3110-K2024-03-220000950170-24-035480NetIncomeLoss
Total assets$153,474,000FY2023as of 2023-12-3110-K2024-03-220000950170-24-035480Assets
Total liabilities$94,811,000FY2023as of 2023-12-3110-K2024-03-220000950170-24-035480Liabilities
Stockholders' equity$58,663,000FY2023as of 2023-12-3110-K2024-03-220000950170-24-035480StockholdersEquity
Operating cash flow-$1,005,000FY20232023-01-01 to 2023-12-3110-K2024-03-220000950170-24-035480NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$0.14 per shareFY20232023-01-01 to 2023-12-3110-K2024-03-220000950170-24-035480EarningsPerShareDiluted
Shares outstanding105,690,922 sharesFY2023as of 2024-03-1310-K2024-03-220000950170-24-035480EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2014-2023, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20232023-01-01 to 2023-12-31$94,635,00010-K2024-03-220000950170-24-035480
RevenueFY20222022-01-01 to 2022-12-31$90,214,00010-K2024-03-220000950170-24-035480
RevenueFY20212021-01-01 to 2021-12-31$75,360,00010-K2024-03-220000950170-24-035480
RevenueFY20202020-01-01 to 2020-12-31$66,499,00010-K2023-03-010000950170-23-005586
RevenueFY20192019-01-01 to 2019-12-31$99,219,00010-K2022-03-010000950170-22-002545
RevenueFY20182018-01-01 to 2018-12-31$77,347,00010-K2021-02-260001564590-21-009198
RevenueFY20172017-01-01 to 2017-12-31$71,834,00010-K2018-03-020001564590-18-004277
RevenueFY20162016-01-01 to 2016-12-31$69,337,00010-K2018-03-020001564590-18-004277
RevenueFY20152015-01-01 to 2015-12-31$51,952,00010-K2018-03-020001564590-18-004277
Net incomeFY20232023-01-01 to 2023-12-31-$13,274,00010-K2024-03-220000950170-24-035480
Net incomeFY20222022-01-01 to 2022-12-31-$19,881,00010-K2024-03-220000950170-24-035480
Net incomeFY20212021-01-01 to 2021-12-31-$11,370,00010-K2024-03-220000950170-24-035480
Net incomeFY20202020-01-01 to 2020-12-31-$27,501,00010-K2023-03-010000950170-23-005586
Net incomeFY20192019-01-01 to 2019-12-31-$18,630,00010-K2022-03-010000950170-22-002545
Net incomeFY20182018-01-01 to 2018-12-31-$79,723,00010-K2021-02-260001564590-21-009198
Net incomeFY20172017-01-01 to 2017-12-31-$50,082,00010-K2020-03-040001564590-20-008538
Net incomeFY20162016-01-01 to 2016-12-31-$30,205,00010-K2019-02-190001564590-19-003187
Net incomeFY20152015-01-01 to 2015-12-31$3,033,00010-K2018-03-020001564590-18-004277
Net incomeFY20142014-01-01 to 2014-12-31-$16,134,00010-K2016-03-240001193125-16-516045
  • Net income for FY2017 was restated: first reported as -$50,080,000 (accession 0001564590-18-004277, filed 2018-03-02).
  • Net income for FY2014 was restated: first reported as -$16,134,158 (accession 0001193125-15-104307, filed 2015-03-25).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-K/A2024-04-052023-12-310000950170-24-042273sctl-20231231.htm
10-K2024-03-222023-12-310000950170-24-035480sctl-20231231.htm
10-Q2023-11-082023-09-300000950170-23-061124sctl-20230930.htm
10-Q2023-08-142023-06-300000950170-23-042534sctl-20230630.htm
10-Q2023-05-102023-03-310000950170-23-020581sctl-20230331.htm
10-K2023-03-012022-12-310000950170-23-005586sctl-20221231.htm
10-Q2022-11-092022-09-300000950170-22-023908sctl-20220930.htm
10-Q2022-08-102022-06-300000950170-22-016481sctl-20220630.htm
10-Q2022-05-112022-03-310000950170-22-009341sctl-20220331.htm
10-K2022-03-012021-12-310000950170-22-002545reph-20211231.htm
10-Q2021-11-092021-09-300000950170-21-003751reph-20210930.htm
10-Q2021-08-092021-06-300000950170-21-001078reph-20210630.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001588972published by the sourcedata.sec.gov/submissions/CIK0001588972.json2026-10-21
Employer Identification Number (EIN) · US-EIN26-1523233published by the sourcedata.sec.gov/submissions/CIK0001588972.json2026-10-21

Former names

NameFromTo
Recro Pharma, Inc.2013-10-242022-03-21

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001588972.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001588972.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001588972" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001588972/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001588972/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1588972"}

On SEC EDGAR

About this data